Drug Price Trends for ADULT ASPIRIN REGIMEN EC

Average Pharmacy Cost for ADULT ASPIRIN REGIMEN EC

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
ADULT ASPIRIN REGIMEN EC 81 MG	70000-0218-01	0.01368	EACH	2025-01-22
ADULT ASPIRIN REGIMEN EC 81 MG	70000-0218-01	0.01317	EACH	2024-12-18
ADULT ASPIRIN REGIMEN EC 81 MG	70000-0218-01	0.01244	EACH	2024-11-20
ADULT ASPIRIN REGIMEN EC 81 MG	70000-0218-01	0.01411	EACH	2024-10-23
ADULT ASPIRIN REGIMEN EC 81 MG	70000-0218-01	0.01452	EACH	2024-09-18
ADULT ASPIRIN REGIMEN EC 81 MG	70000-0218-01	0.01539	EACH	2024-08-21

Market Analysis and Price Projections for Adult Aspirin Regimen EC

Market Overview

The global aspirin market, which includes adult aspirin regimen EC, is a mature and dynamic sector driven by several key factors. Here is a comprehensive analysis of the market, including its current state, future projections, and key drivers.

Market Size and Growth Projections

As of 2022, the global aspirin market was valued at approximately USD 2.356 billion. It is expected to grow to around USD 2.917 billion by 2030, with a compound annual growth rate (CAGR) of about 2.70% to 4.62% between 2023 and 2030[2][3].

Forecast Period

The forecast period from 2023 to 2030 indicates steady growth, with some projections suggesting the market could reach USD 3.42 billion by 2030 at a CAGR of 4.62%[2].

Key Drivers of Market Growth

Increasing Prevalence of Chronic Diseases

The rising global incidence of chronic diseases such as cardiovascular diseases, hypertension, and other inflammatory conditions is a significant driver of the aspirin market. Aspirin is widely used for its anti-inflammatory and antiplatelet properties, making it a staple in managing these conditions[1][2][3].

Growing Geriatric Population

The increasing geriatric population is another crucial factor. Older adults are more susceptible to chronic diseases, which in turn increases the demand for aspirin. This demographic shift is expected to continue driving market growth[1][2][3].

Expanding Applications

Aspirin's potential in cancer prevention and treatment of dementia is opening new therapeutic avenues. Research into these areas is expected to boost market growth, as aspirin shows effects on both COX-dependent and independent mechanisms[1][3].

Technological Advancements in Drug Delivery Systems

Technological developments in drug delivery systems have led to the creation of aspirin formulations with variable release times. These formulations offer controlled aspirin release, enabling once-daily dosing and possibly minimizing gastrointestinal adverse effects, which improves patient adherence and supports market expansion[1].

Market Segmentation

By Route of Administration

The oral route of administration dominates the aspirin market due to the rising prevalence of cardiac disorders among the population. Other routes include rectal and parenteral administration[1].

By Dosage Form

The market is segmented into tablets, capsules, injections, and suppositories. Tablets are the most common dosage form due to their ease of administration and widespread use[1].

By Applications

The market is segmented into pain/fever/inflammation, cardiovascular disease, and other applications. The pain/fever/inflammation segment has seen the highest growth due to aspirin's primary function in relieving mild to moderate body aches and headaches[2][3].

By Distribution Channels

The market is categorized into online and offline sales channels. Offline channels currently hold a significant market share, but online channels are growing rapidly due to increased internet penetration and consumer preference for online shopping, especially during the COVID-19 pandemic[2][3].

Regional Market Analysis

Asia-Pacific Region

The Asia-Pacific region, particularly China and India, is expected to witness the highest growth due to the robust pharmaceutical industry and large population base. These countries are leaders in the production of Active Pharmaceutical Ingredients (APIs) and have a high demand for basic medicines like aspirin[1][2][3].

North America

The United States is expected to seize a significant global market share, driven by the increasing need for aspirin to manage chronic pain. Chronic pain, especially in adults, is rising in the United States due to lifestyle factors such as prolonged sitting[3].

Price Trends and Projections

Current Prices

As of recent quarters, the price of aspirin has been around USD 3,380 per metric ton in the USA. For specific products like HM ASPIRIN EC 81 MG TABLET, prices range from USD 0.01244 to USD 0.01452 per unit[2].

Future Projections

While specific price projections for aspirin are not provided, the overall market growth and increasing demand are likely to influence pricing. However, the impact of generic versions of aspirin, which are significantly cheaper than branded products, could stabilize or even reduce prices in some regions[2].

Market Restraints

Side Effects and Alternative Medications

Aspirin's gastrointestinal side effects and increased risk of bleeding are major restraints. Additionally, the availability of alternative medications with improved efficacy and fewer side effects poses a challenge to the market[1][2][4].

Regulatory Constraints

Stringent regulatory requirements for the approval of new formulations and applications of aspirin also limit market growth. Health organizations like the USPSTF have updated recommendations on aspirin use, which can impact market dynamics[1][2][5].

Key Takeaways

• Market Growth: The aspirin market is expected to grow at a CAGR of 2.70% to 4.62% from 2023 to 2030.
• Key Drivers: Increasing prevalence of chronic diseases, growing geriatric population, and expanding applications.
• Market Restraints: Side effects, alternative medications, and regulatory constraints.
• Regional Growth: Asia-Pacific region, particularly China and India, is expected to witness the highest growth.
• Price Trends: Current prices around USD 3,380 per metric ton in the USA, with future prices influenced by market growth and generic versions.

"PA32540 use to prevent recurrent CV events was associated with cost reductions in each year examined with the model. From a health plan perspective, PA32540 is likely to have a net overall effect, resulting in significant cost savings."[4]

FAQs

Q: What is the expected CAGR of the global aspirin market from 2023 to 2030?

A: The global aspirin market is expected to grow at a CAGR of 2.70% to 4.62% from 2023 to 2030[2][3].

Q: Which region is expected to dominate the aspirin market?

A: The Asia-Pacific region, particularly China and India, is expected to witness the highest growth due to the robust pharmaceutical industry and large population base[1][2][3].

Q: What are the primary drivers of the aspirin market?

A: The primary drivers include the increasing prevalence of chronic diseases, growing geriatric population, and expanding applications of aspirin[1][2][3].

Q: What are the major restraints to the aspirin market?

A: The major restraints include aspirin's gastrointestinal side effects, increased risk of bleeding, availability of alternative medications, and regulatory constraints[1][2][4].

Q: How does the USPSTF recommend the use of aspirin for cardiovascular disease prevention?

A: The USPSTF recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults 60 years or older and suggests an individual decision for adults aged 40 to 59 years with a 10% or greater 10-year CVD risk[5].

Sources

1. Data Bridge Market Research: Global Aspirin Market – Industry Trends and Forecast to 2030.
2. DrugPatentWatch: Market Analysis and Financial Projection for Aspirin.
3. Future Market Insights: Aspirin Drug Market Size, Share & Forecast to 2034.
4. PubMed: The budget impact of using enteric-coated aspirin 325 mg.
5. US Preventive Services Task Force: Recommendation: Aspirin Use to Prevent Cardiovascular Disease.

Last updated: 2025-01-10